Editing Inhaler (section)

===Chronic obstructive pulmonary disease (COPD)===

COPD is an obstructive lung disease due to long-term damage to the airways of the lungs. The long-term damage leads to the inability of the airways to open properly, causing [[airway obstruction]]. Inhaled medications allow patients to see improvement in symptoms and better function of daily living. Some commonly used inhaled medications in patient's with COPD are [[Ipratropium bromide|ipratroprium]], [[salmeterol]], and [[corticosteroid]]s.<ref name=":2" /> Inhalers that combine two or three different medications including inhaled corticosteroids, long-active muscarinic medications (LAMA) and long acting beta2 agonists (LABA) for treating COPD may be associated with improvements in some quality of life variables and small improvements in lung function and respiratory symptoms, however, may also be associated with an increase in the risk of pneumonia.<ref>{{Cite journal |last1=van Geffen |first1=Wouter H. |last2=Tan |first2=Daniel J. |last3=Walters |first3=Julia Ae |last4=Walters |first4=E. Haydn |date=2023-12-06 |title=Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease |journal=The Cochrane Database of Systematic Reviews |volume=2023 |issue=12 |pages=CD011600 |doi=10.1002/14651858.CD011600.pub3 |issn=1469-493X |pmc=10698842 |pmid=38054551}}</ref>